This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Newfield Therapeutics Corporation. Active years: 2016-2018.
Company Filing History:
Years Active: 2016-2018
Title: Innovations in Cancer Treatment by Sabrina Riedl
Introduction
Sabrina Riedl is an accomplished inventor based in Frauental an der Lassnitz, Austria. She has made significant contributions to the field of cancer treatment through her innovative research and development of peptides. With a total of 2 patents, her work is paving the way for new therapeutic options in oncology.
Latest Patents
Riedl's latest patents focus on isolated peptides designed for the treatment of cancer. These peptides consist of 12 to 50 amino acid residues and are characterized by their structural features, including at least two beta-strands or alpha-helices. The peptides possess a net positive charge of +7 or more, which is crucial for their therapeutic efficacy. The specific amino acid sequences and structural properties of these peptides are meticulously designed to enhance their effectiveness in targeting cancer cells.
Career Highlights
Sabrina Riedl is currently associated with Newfield Therapeutics Corporation, where she continues her groundbreaking work in peptide research. Her innovative approach and dedication to cancer treatment have positioned her as a key figure in the field.
Collaborations
Riedl collaborates with notable colleagues, including Dagmar Zweytick and Karl Lohner, who contribute to her research endeavors. Their combined expertise enhances the potential impact of their work in cancer therapy.
Conclusion
Sabrina Riedl's contributions to cancer treatment through her innovative peptide research exemplify the importance of scientific advancements in medicine. Her work not only showcases her talent as an inventor but also holds promise for improving patient outcomes in the fight against cancer.